—
Executive Summary:Onychomycosis is a condition of fungal nail infection. Onychomycosis begins in the nail bed and progresses to the nail plate, causing the nail to become discolored, deformed, and even separated from the nail bed. Onychomycosis has a significant chance of reoccurrence. Of all the nail abnormalities in the world, around 50% are the case of onychomycosis. In most of the cases it occurs in the toenails. Onychomycosis is not a life threatening disease but, may persist or worsen if not treated.
Request a sample of this report @ https://www.orbisresearch.com/contacts/request-sample/3578768
Symptoms of onychomycosis are changes in appearance of the nail, interference with standing, walking, and exercising, pain, discomfort, etc. The causative pathogens of onychomycosis include dermatophytes (most common), Candida, and nondermatophytic molds.
There are five types of Onychomycosis:
• Distal Subungual Onychomycosis
• White superficial onychomycosis
• Proximal subungual onychomycosis
• Endonyx onychomycosis and
• Candidal onychomycosis
Two types of treatments are available of onychomycosis: Oral Treatment and Topical Treatment. Oral treatment includes: Terbinafine, Itraconazole, etc. and topical treatment includes Kerydin, Jublia, etc. Nonpharmacologic approaches are also there, which includes the following: Laser treatment, Photodynamic therapy, etc.
The US onychomycosis market is forecasted to grow at a healthy growth rate during the forecast period (2019-2023). The US onychomycosis market is supported by various growth drivers, such as rising per capita healthcare expenditure, increasing diabetic patients, ageing population, introduction of new drugs, etc. Yet, the market faces certain challenges, such as, reimbursements, low awareness, side effects, etc.
Place a purchase order of this report @ https://www.orbisresearch.com/contact/purchase-single-user/3578768
Company Coverage:
• Bausch Health Companies (Formerly Valeant Pharmaceuticals)
• Pfizer, Inc.
• Johnson and Johnson
• Novartis AG
Scope of the Report:
The report entitled “The US Onychomycosis Market: Size, Trends & Forecasts (2019-2023 Edition)”, provides analysis of the US onychomycosis market, with detailed analysis of market size in terms of value, volume and segments. The report also includes the analysis of the larger nail care market in order to showcase the position of onychomycosis with respect to the nail care industry.
Under competitive landscape, different players in the onychomycosis industry have been compared on the basis of parameters such as revenue and market capitalization.
Bausch Health Companies (Formerly Valeant Pharmaceuticals), Pfizer, Inc., Novartis AG and Johnson & Johnson are some of the key players operating in the US onychomycosis market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.
Browse the complete report @ https://www.orbisresearch.com/reports/index/the-us-onychomycosis-market-size-trends-and-forecasts-2019-2023-edition
Some Points from Table of Content:
1. Executive Summary
2. Introduction
2.1 Onychomycosis: An Overview
2.1.1 Signs and Symptoms
2.1.2 Causes of Onychomycosis
2.2 Types of Onychomycosis
2.3 Treatment for Onychomycosis
3. Global Market Analysis
3.1 Global Nail Care Market: An Analysis
3.1.1 Global Nail Care Market by Value
3.1.2 Global Nail Care Market by Segment (Onychomycosis (Antifungal Medications and Non Pharmacological Products) and Other Nail Care Products)
3.2 Global Onychomycosis Market: An Analysis
3.2.1 Global Onychomycosis Market by Value
3.2.2 Global Onychomycosis Market by Segment
3.2.3 Global Kerydin Drugs Market by Value
3.2.4 Global Jublia Drugs Market by Value
3.3 Global Onychomycosis Market: Pipeline Drugs Analysis
3.3.1 Phase II Drugs (Onychomycosis) Pipeline Forecast
3.3.2 Phase III Drugs (Onychomycosis) Pipeline Forecast
3.4 Onychomycosis Market: New Drugs Overview
3.5 Global Onychomycosis Market: Country Analysis
3.5.1 Global Onychomycosis Market by Countries
4. The US Market Analysis
4.1 The US Nail Care Market: An Analysis
4.1.1 The US Nail Care Market by Value
4.1.2 The US Nail Care Market by Segments Segment (Onychomycosis (Antifungal Medications and Non Pharmacological Products) and Other Nail Care Products)
4.2 The US Onychomycosis Market: An Analysis
4.2.1 The US Onychomycosis Market by Value
4.3 The US Onychomycosis Market: Type of Treatment Analysis
…………..Continued
Make an enquiry of this report @ https://www.orbisresearch.com/contacts/enquiry-before-buying/3578768
Some Points from List of Figures:
Figure 1: Types of Onychomycosis
Figure 2: Treatment for Onychomycosis
Figure 3: Global Nail Care Market by Value; 2017-2018 (US$ Billion)
Figure 4: Global Nail Care Market by Value; 2019-2023 (US$ Billion)
Figure 5: Global Nail Care Market by Segments; 2018 (Percentage, %)
Figure 6: Global Onychomycosis Market by Value; 2017-2018 (US$ Billion)
Figure 7: Global Onychomycosis Market by Value; 2019-2023 (US$ Billion)
Figure 8: Global Onychomycosis Market by Segments; 2018 (Percentage, %)
Figure 9: Global Kerydin Drugs Market by Value; 2017-2018 (US$ Million)
Figure 10: Global Kerydin Drugs Market by Value; 2019-2023 (US$ Million)
Figure 11: Global Jublia Drugs Market by Value; 2017-2018 (US$ Million)
Figure 12: Global Jublia Drugs Market by Value; 2019-2023 (US$ Million)
Figure 13: Phase II Drugs (Onychomycosis) Pipeline Forecast; 2021-2026 (US$ Million)
Figure 14: Phase III Drugs (Onychomycosis) Pipeline Forecast; 2018-2026 (US$ Million)
Figure 15: Global Onychomycosis Market by Countries; 2018 (Percentage,%)
Figure 16: The US Nail Care Market by Value; 2017–2018 (US$ Billion)
Figure 17: The US Nail Care Market by Value; 2019–2023 (US$ Billion)
Figure 18: The US Nail Care Market by Segments; 2018 (Percentage,%)
Figure 19: The US Onychomycosis Market by Value; 2017–2018 (US$ Billion)
Figure 20: The US Onychomycosis Market by Value; 2019–2023 (US$ Billion)
……..Continued
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Info:
Name: Hector Costello
Email: Send Email
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600
Phone: +1 (214) 884-6817
Website: https://www.orbisresearch.com/reports/index/the-us-onychomycosis-market-size-trends-and-forecasts-2019-2023-edition
Release ID: 88910451
Google
RSS